THE RISK OF MISCARRIAGE FOLLOWING IMMUNIZATION OF THE BIVALENT HUMAN PAPILLOMAVIRUS (HPV) - 16/18 VACCINE: A BAYESIAN APPROACH
Background: Cervarix is a prophylactic vaccine used in preventing cervical cancer associated with human papillomavirus types 16/18. A previous study that investigated the risk of miscarriage associated with this bivalent vaccine by pooled analysis of data from two clinical trials, showed a numerical...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en en |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1974/7790 |